This article presents updated evidence-based guidelines on the therapeutic use of repetitive transcranial magnetic stimulation (rTMS) based on publications from 2014 to 2018. The guidelines cover various neurological and psychiatric disorders, with a focus on pain, movement disorders, and depression. For neuropathic pain, high-frequency (HF) rTMS of the primary motor cortex (M1) contralateral to the painful side is recommended for definite efficacy. For depression, HF-rTMS of the left dorsolateral prefrontal cortex (DLPFC) is recommended for probable efficacy. For post-acute stroke, low-frequency (LF) rTMS of contralateral M1 is recommended for improving hand motor recovery. Other conditions, such as fibromyalgia, Parkinson's disease, and multiple sclerosis, also show varying levels of evidence for rTMS efficacy. The guidelines emphasize the importance of methodological quality in studies and the need for larger, longer-term trials to confirm the clinical relevance of rTMS treatments.This article presents updated evidence-based guidelines on the therapeutic use of repetitive transcranial magnetic stimulation (rTMS) based on publications from 2014 to 2018. The guidelines cover various neurological and psychiatric disorders, with a focus on pain, movement disorders, and depression. For neuropathic pain, high-frequency (HF) rTMS of the primary motor cortex (M1) contralateral to the painful side is recommended for definite efficacy. For depression, HF-rTMS of the left dorsolateral prefrontal cortex (DLPFC) is recommended for probable efficacy. For post-acute stroke, low-frequency (LF) rTMS of contralateral M1 is recommended for improving hand motor recovery. Other conditions, such as fibromyalgia, Parkinson's disease, and multiple sclerosis, also show varying levels of evidence for rTMS efficacy. The guidelines emphasize the importance of methodological quality in studies and the need for larger, longer-term trials to confirm the clinical relevance of rTMS treatments.